BOKU - Universität für Bodenkultur Wien - Forschungsinformationssystem

Logo BOKU-Forschungsportal

Gewählte Publikation:

Kolarich D, Weber A, Pabst M, Stadlmann J, Teschner W, Ehrlich H, Schwarz HP, Altmann F..
(2008): Glycoproteomic characterization of butyrylcholinesterase from human plasma.
PROTEOMICS, 18, 254-263; ISSN 1615-9853

Abstract:
Human butyrylcholinesterase (hBChE) is a highly glycosylated protein present in human plasma. The enzyme hydrolyses choline esters, for example benzoylcholine, butyrylthiocholine and acetylthiocholine as well as noncholine esters like heroin and aspirin. hBChE is primarily involved in neuronal transmission and is a potential bioscavenger of toxic organophosphates to protect acetylcholinesterase. A prerequisite for the therapeutic use of hBChE is a detailed characterization of this glycoprotein purified from human plasma. In this study, MS/MS could confirm most of the protein backbone, including the N- and the C-terminus. Site-specific analysis of all nine potential N-glycosylation sites revealed mainly mono- and disialylated N-glycans to be present on this glycoprotein. Sialic acids (Neu5Ac) are mainly alpha 2,6-linked, however a fraction of the N-glycans contained Neu5Ac also in alpha 2,3 linkage. On monosialylated N-glycans, sialic acid is exclusively located on the 3-arm and in alpha 2,6 linkage, as verified by 2D-HPLC and exoglycosidase digests of 2-aminopyridine (PA)-labelled N-glycans. This first comprehensive glycoproteomic analysis of the important human plasma glycoprotein BChE did not give any indication of O-glycosylation or any other kind of PTMs as previously postulated.
Autor*innen der BOKU Wien:
Altmann Friedrich
Pabst Martin
Stadlmann Johannes
BOKU Gendermonitor:


Find related publications in this database (Keywords)
aminopyricline
butyrylcholinesterase
glycoproteomics
N-glycan
porous graphitized carbon


© BOKU Wien Impressum